Omnicell
OMCL on Nasdaq. Omnicell sells medication management systems to hospitals and pharmacies. Market value $1.6bn.
Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.
We can't read total debt from the filing, so debt is left out.
Should I look at this?
Not a fit for our list right now
Why it could be worth it
What to watch out for
See Technology stocks that passed both tests
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $8.82 of spare cash in the past 12 months. A savings account pays about $4.
The filings do not give us enough to work this out.
The filings do not give us enough to work this out.
Quality score: 60 of 100. Price score: 63 of 100. Our list needs 70 on quality and 60 on price.
$35.46 a share, 22% above its 1-year low
Over the past year the price has ranged from $29.06 to $55.00.
Pays no dividend
Prices from Tuesday’s close (6 October).
Five years of cash, in billions
Spare cash swings from quarter to quarter here: $143 million in the past 12 months, $87 million in the year to December 2025.
| Revenue | |||||
| Revenue | $1.1bn | $1.3bn | $1.1bn | $1.1bn | $1.2bn |
| Operating margin | |||||
| Operating margin | 7.9% | -0.2% | -3.0% | 0.0% | 0.4% |
| Debt to equity | |||||
| Debt to equity | n/a | n/a | n/a | n/a | n/a |
| Shares outstanding | |||||
| Shares outstanding | 0.04bn | 0.05bn | 0.05bn | 0.04bn | 0.05bn |
Health checks
- Free cash flow positive5 of 5 years
- Accounting looks honest (Beneish)Not enough data
- Financial strength (Piotroski)8 of 8 checks we could run
- Profit backed by cash (accruals)Yes
- DebtUnknown
- Revenue growth, five yearsSlow, 5.8% a year
- Buying back its own sharesRoughly flat
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $312 million last quarter, up 7% on a year ago.
- Profit: $24 million, up 331% on a year ago.
- It keeps 5 cents of each $1 of sales as operating profit, up from 1 cents a year earlier.
- Spare cash over the past 12 months: $143 million, up from $107 million.
- 1% fewer shares than a year ago. Each share owns a bit more of the company.
- Sales grew on a year ago in each of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| September 2024 | $282m |
| December 2024 | $307m |
| March 2025 | $270m |
| June 2025 | $291m |
| September 2025 | $311m |
| December 2025 | $314m |
| March 2026 | $310m |
| June 2026 | $312m |
| Quarter to | Amount |
|---|---|
| September 2024 | $9m |
| December 2024 | $16m |
| March 2025 | -$7m |
| June 2025 | $6m |
| September 2025 | $5m |
| December 2025 | -$2m |
| March 2026 | $11m |
| June 2026 | $24m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 26 February 2026
- Next quarterly (estimated, 10-Q)
- 4 November 2026
Who owns it
4 long-term investors we follow own it, up from 3 last quarter. 306 funds in all.
- LSV Asset ManagementJosef Lakonishok
- Value
- $133,000
- Share of fund
- <0.1%
| Fund | Value | Share of that fund | Change |
|---|---|---|---|
| Boston PartnersBoston Partners team | $22m | <0.1% | Cut |
| Gotham Asset ManagementJoel Greenblatt | $2m | <0.1% | New |
| LSV Asset ManagementJosef Lakonishok | $133,000 | <0.1% | |
| Barrow HanleyBarrow Hanley team | $4,775 | <0.1% | Added |
Largest holders overall
- BlackRock$313mAdded
- Vanguard Portfolio Management$131m
- Wellington Management Group LLP$112m
- Dimensional Fund Advisors LP$102m
- State Street$87mAdded
- Vanguard Capital Management$82m
- Millennium Management$72mCut
- Nomura Asset Management International$67mAdded
- Geode Capital Management$51mAdded
- Nuveen$43mAdded
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
6 investors own more than 5%.
- BlackRock, Inc.Passive investor15.3%Since 31 March 2025
- Vanguard Portfolio ManagementPassive investor7.1%Since 31 March 2026
- Wellington Management Group LLPPassive investorat least 6.0%(filed with 3 related holders)Since 31 March 2026
- Dimensional Fund Advisors LPPassive investor5.1%Since 30 September 2025
- Vanguard Capital ManagementPassive investor5.0%Since 31 March 2026
- Millennium Management LLCPassive investorat least 3.8%−1.2 pts(filed with 2 related holders)Since 30 June 2026
- The Vanguard GroupPassive investorSold down below 5%Since 13 March 2026
| Holder | Stake | Since | |
|---|---|---|---|
BlackRock, Inc. Passive investor | 15.3% | 31 March 2025 | |
Vanguard Portfolio Management Passive investor | 7.1% | 31 March 2026 | |
Wellington Management Group LLP Passive investor | at least 6.0% (filed with 3 related holders) | 31 March 2026 | |
Dimensional Fund Advisors LP Passive investor | 5.1% | 30 September 2025 | |
Vanguard Capital Management Passive investor | 5.0% | 31 March 2026 | |
Millennium Management LLC Passive investor | at least 3.8%−1.2 pts (filed with 2 related holders) | 30 June 2026 | |
The Vanguard Group Passive investor | Sold down below 5% | 13 March 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought shares on the open market in the last 12 months. 3 sold $3m, $3m of it under preset trading plans.
- Njoku NnamdiPresident & COOSoldunder a preset trading plan
- Date
- 17 August 2026
- Shares
- 3,083
- Price
- $36.85
- Value
- $113,609
- LIPPS RANDALL ACHAIRMAN, CEO, DirectorSoldunder a preset trading plan
- Date
- 15 July 2026
- Shares
- 10,000
- Price
- $47.00
- Value
- $470,000
- Njoku NnamdiEVP, Chief Operating OfficerSoldunder a preset trading plan
- Date
- 18 May 2026
- Shares
- 3,090
- Price
- $43.22
- Value
- $133,550
- Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERSoldunder a preset trading plan
- Date
- 18 May 2026
- Shares
- 5,025
- Price
- $43.22
- Value
- $217,181
- Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERSoldunder a preset trading plan
- Date
- 16 March 2026
- Shares
- 7,405
- Price
- $34.69
- Value
- $256,879
- Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERSoldunder a preset trading plan
- Date
- 17 February 2026
- Shares
- 4,243
- Price
- $36.59
- Value
- $155,251
- Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERSoldunder a preset trading plan
- Date
- 8 January 2026
- Shares
- 6,106
- Price
- $49.90
- Value
- $304,689
- Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERSold
- Date
- 16 December 2025
- Shares
- 278
- Price
- $43.30
- Value
- $12,037
- Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERSoldunder a preset trading plan
- Date
- 3 December 2025
- Shares
- 6,106
- Price
- $39.90
- Value
- $243,629
- LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEO, DirectorSoldunder a preset trading plan
- Date
- 1 December 2025
- Shares
- 28,250
- Price
- $35.97
- Value
- $1m
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 17 August 2026 | Njoku Nnamdi President & COO | Sold under a preset trading plan | 3,083 | $36.85 | $113,609 |
| 15 July 2026 | LIPPS RANDALL A CHAIRMAN, CEO, Director | Sold under a preset trading plan | 10,000 | $47.00 | $470,000 |
| 18 May 2026 | Njoku Nnamdi EVP, Chief Operating Officer | Sold under a preset trading plan | 3,090 | $43.22 | $133,550 |
| 18 May 2026 | Manley Corey J EVP&CHIEF LEGAL/ADMIN OFFICER | Sold under a preset trading plan | 5,025 | $43.22 | $217,181 |
| 16 March 2026 | Manley Corey J EVP&CHIEF LEGAL/ADMIN OFFICER | Sold under a preset trading plan | 7,405 | $34.69 | $256,879 |
| 17 February 2026 | Manley Corey J EVP&CHIEF LEGAL/ADMIN OFFICER | Sold under a preset trading plan | 4,243 | $36.59 | $155,251 |
| 8 January 2026 | Manley Corey J EVP&CHIEF LEGAL/ADMIN OFFICER | Sold under a preset trading plan | 6,106 | $49.90 | $304,689 |
| 16 December 2025 | Manley Corey J EVP&CHIEF LEGAL/ADMIN OFFICER | Sold | 278 | $43.30 | $12,037 |
| 3 December 2025 | Manley Corey J EVP&CHIEF LEGAL/ADMIN OFFICER | Sold under a preset trading plan | 6,106 | $39.90 | $243,629 |
| 1 December 2025 | LIPPS RANDALL A CHAIRMAN, PRESIDENT AND CEO, Director | Sold under a preset trading plan | 28,250 | $35.97 | $1m |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
None of the warning signs we check for were found.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 26 Feb 2026, plus the 10-Q filed 5 Aug 2026 and 4 later 8-Ks.
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
Cheap for a reason is the question the numbers cannot answer.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.